文献速递认知障碍与痴呆帕金森病与运动障碍

tau与β淀粉样蛋白PET在额颞叶变性中的敏感性-特异性

Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.
PubMed 文献 · Ann Neurol · 2020-09-12

Flortaucipir与内嗅皮层神经原纤维缠结计数相关,但内嗅和meta-ROI SUVR在Braak IV或原发性年龄相关tau病中未升高。Flortaucipir摄取模式可区分皮质基底节变性与进行性核上性麻痹。

要点

  • Flortaucipir PET对FTLD中轻度阿尔茨海默病理缺乏敏感性。
  • Flortaucipir摄取模式可区分皮质基底节变性与进行性核上性麻痹。
  • PiB SUVR与Aβ斑块计数相关,弥漫斑块敏感性50%、特异性100%。

核心结论

  • 分子PET与阿尔茨海默相关病理显示预期相关性,但缺乏检测FTLD中轻度阿尔茨海默病理的敏感性。
  • 区域flortaucipir摄取能够区分皮质基底节变性与进行性核上性麻痹。

研究设计与样本

  • 除1例外均行Pittsburgh compound B(PiB)-PET,并完成Braak分期、Aβ斑块和神经原纤维缠结计数及半定量tau病变评分。
  • 计算内嗅皮层、颞叶meta-ROI及与tau病变分析匹配的皮层/皮层下区域flortaucipir SUVR,并计算全局PiB SUVR。
  • 对1例进行性核上性麻痹患者行放射自显影,用数字病理量化tau负荷。

主要发现

  • 9例(37.5%)有Aβ斑块。
  • 全局PiB SUVR与Aβ斑块计数相关,对弥漫斑块敏感性50%、特异性100%。
  • Flortaucipir与内嗅皮层神经原纤维缠结计数相关,但内嗅和meta-ROI SUVR在Braak IV或原发性年龄相关tau病中未升高。
  • Flortaucipir摄取模式在不同FTLD病理间不同,可区分进行性核上性麻痹与皮质基底节变性。

关键数值与推荐

  • 全局PiB SUVR对弥漫Aβ斑块的敏感性为50%、特异性为100%。

临床怎么用

  • Flortaucipir PET可用于区分皮质基底节变性与进行性核上性麻痹。
  • 在FTLD患者中解读tau PET时应警惕其对轻度阿尔茨海默病理的低敏感性。

局限性

  • 放射自显影仅进行于1例进行性核上性麻痹患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine associations between tau and amyloid β (Aβ) molecular positron emission tomography (PET) and both Alzheimer-related pathology and 4-repeat tau pathology in autopsy-confirmed frontotemporal lobar degeneration (FTLD). METHODS: Twenty-four patients had [18 F]-flortaucipir-PET and died with FTLD (progressive supranuclear palsy [PSP], n = 10; corticobasal degeneration [CBD], n = 10; FTLD-TDP, n = 3; and Pick disease, n = 1). All but 1 had Pittsburgh compound B (PiB)-PET. Braak staging, Aβ plaque and neurofibrillary tangle counts, and semiquantitative tau lesion scores were performed. Flortaucipir standard uptake value ratios (SUVRs) were calculated in a temporal meta region of interest (meta-ROI), entorhinal cortex and cortical/subcortical regions selected to match the tau lesion analysis. Global PiB SUVR was calculated. Autoradiography was performed in 1 PSP patient, with digital pathology used to quantify tau burden. RESULTS: Nine cases (37.5%) had Aβ plaques. Global PiB SUVR correlated with Aβ plaque count, with 100% specificity and 50% sensitivity for diffuse plaques. Twenty-one (87.5%) had Braak stages I to IV. Flortaucipir correlated with neurofibrillary tangle counts in entorhinal cortex, but entorhinal and meta-ROI SUVRs were not elevated in Braak IV or primary age-related tauopathy. Flortaucipir uptake patterns differed across FTLD pathologies and could separate PSP and CBD. Flortaucipir correlated with tau lesion score in red nucleus and midbrain tegmentum across patients, but not in cortical or basal ganglia regions. Autoradiography demonstrated minimal uptake of flortaucipir, although flortaucipir correlated with quantitative tau burden across regions. INTERPRETATION: Molecular PET shows expected correlations with Alzheimer-related pathology but lacks sensitivity to detect mild Alzheimer pathology in FTLD. Regional flortaucipir uptake was able to separate CBD and PSP. ANN NEUROL 2020;88:1009-1022.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Ghirelli A, Tosakulwong N, Weigand SD, et al. Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration. Ann Neurol. 2020. PMID: 32869362. doi:10.1002/ana.25893

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。